Related Experiment Videos

Alternative splicing of the FHIT gene in colorectal cancers

K Hibi1, M Taguchi, H Nakamura

  • 1Second Department of Surgery, Nagoya University School of Medicine, Showa-ku.

Insights

Researchers investigated the FHIT gene in colorectal tumors, finding alternative splicing that removed exon 4 in 5 specimens. These tumors, linked to the FHIT gene, were located in the lower rectum.

Area of Science:

  • Molecular biology
  • Oncology
  • Genetics

Background:

  • The FHIT (Fragile histidine triad) gene is a tumor suppressor gene.
  • Alterations in FHIT gene expression are implicated in various cancers.
  • Understanding FHIT gene status is crucial for colorectal cancer research.

Purpose of the Study:

  • To investigate the status of the FHIT gene in colorectal cancer and adenoma specimens.
  • To identify any alterations in FHIT gene splicing.
  • To correlate FHIT gene alterations with tumor location.

Main Methods:

  • Analysis of 112 colorectal cancer and 137 colorectal adenoma specimens.
  • Detection of FHIT gene products using molecular techniques.
  • Correlation of alternative splicing events with tumor location relative to the anterior peritoneal reflection.

Main Results:

  • A smaller FHIT gene product, lacking exon 4 due to alternative splicing, was detected in 5 specimens (4 colorectal cancers, 1 adenoma).
  • This alternative splicing event involved the 5' noncoding region of the FHIT gene.
  • All tumors exhibiting this alternative splicing were located in the lower rectum, below the anterior peritoneal reflection.

Conclusions:

  • Alternative splicing of the FHIT gene, resulting in the loss of exon 4, occurs in a subset of colorectal tumors.
  • This specific FHIT gene alteration is associated with tumors located in the lower rectum.
  • Further research is warranted to elucidate the functional and clinical significance of FHIT gene alternative splicing in colorectal carcinogenesis.

Related Concept Videos